AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $4,892,610 | +73.0% | 213,000 | +113.0% | 0.99% | +79.6% |
| Q3 2022 | $2,828,000 | +206.4% | 100,000 | +400.0% | 0.55% | +107.2% |
| Q3 2021 | $923,000 | -44.2% | 20,000 | -33.3% | 0.26% | -41.8% |
| Q2 2021 | $1,653,000 | -25.6% | 30,000 | -30.2% | 0.46% | -28.3% |
| Q1 2021 | $2,221,000 | -31.7% | 43,000 | -42.7% | 0.64% | -34.3% |
| Q4 2020 | $3,250,000 | -22.6% | 75,000 | -37.5% | 0.97% | -24.7% |
| Q3 2020 | $4,200,000 | -47.6% | 120,000 | -20.0% | 1.28% | -46.5% |
| Q2 2020 | $8,022,000 | +50.7% | 150,000 | 0.0% | 2.40% | +2.5% |
| Q1 2020 | $5,322,000 | -41.3% | 150,000 | -21.1% | 2.34% | -33.7% |
| Q4 2019 | $9,073,000 | – | 190,000 | – | 3.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |